Clinical Trials Directory

Trials / Completed

CompletedNCT03006640

Subcutaneous NTG for US Radial Artery Cannulation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
AlRefaey Kandeel · Academic / Other
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Clinicians are increasingly dealing with morbid obese patients. In morbid obese patients, difficult sampling and problems encountered with noninvasive blood pressure monitoring makes arterial cannulation an essential skill in many situations like surgeries or trans-radial procedures for coronary or carotid interventions. Radial artery has been preferred over other sites for arterial cannulation due to low incidence of bleeding, better hemostats, more comfort, and immediate ambulation. sm In this study, subcutaneous nitroglycerin will be used to facilitate radial artery cannulation aiming to decrease insertion time, increase success rate and decrease related complications

Conditions

Interventions

TypeNameDescription
DRUGSubcutaneous nitroglycrinIn both groups, a 1 ml filled insulin syringe is delivered to a blinded operator who infiltrated it subcutaneously over 1 cm along the radial artery course. In the NTG group, the syringe contains 200 µg of NTG while in control group the syringe is filled with saline
DRUGSubcutaneous salineIn both groups, a 1 ml filled insulin syringe is delivered to a blinded operator who infiltrated it subcutaneously over 1 cm along the radial artery course. In the NTG group, the syringe contains 200 µg of NTG while in control group the syringe is filled with saline

Timeline

Start date
2016-01-01
Primary completion
2016-06-01
Completion
2016-11-01
First posted
2016-12-30
Last updated
2016-12-30

Source: ClinicalTrials.gov record NCT03006640. Inclusion in this directory is not an endorsement.